Evidence map›Paper›PMID 39013440›Full record

ArticleThe clinical respiratory journal2024

Clinical Characteristics of Hospitalized Patients With COVID-19 and Their Association With the Progression to Critical Illness and Death: A Single-Center Retrospective Study From Northwestern Mexico.

Francisco A Martínez-Villa, Uriel A Angulo-Zamudio, Nidia Leon-Sicairos, Ricardo González-Esparza, Jaime Sanchez-Cuen, Jesus J Martinez-Garcia, Hector Flores-Villaseñor, Julio Medina-Serrano, Adrian Canizalez-Roman

Abstract read
In one paragraph

Article in The clinical respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francisco A Martínez-VillaSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Uriel A Angulo-ZamudioSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID https://orcid.org/0000-0003-2733-0766
Nidia Leon-SicairosSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Ricardo González-EsparzaSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Jaime Sanchez-CuenSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Jesus J Martinez-GarciaSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Hector Flores-VillaseñorSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.
Julio Medina-SerranoResearch Department, Coordinación de Investigación en Salud, Delegacion IMSS, Culiacan, Sinaloa, Mexico.
Adrian Canizalez-RomanSchool of Medicine, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico.ORCID https://orcid.org/0000-0001-8605-0639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study was to associate the epidemiological and clinical characteristics of patients hospitalized for COVID-19 with the progression to critical illness and death in northwestern Mexico.

methodsFrom March to October 2020, we collected the demographic and clinical characteristics of 464 hospitalized patients from northwestern Mexico.

resultsSixty-four percent (295/464) of the patients became critically ill. Age, occupation, steroid and antibiotic use at previous hospitalization, and underlying diseases (hypertension, obesity, and chronic kidney disease) were associated with critical illness or death (p: < 0.05). No symptoms were associated with critical illness. However, the parameters such as the heart rate, respiratory rate, oxygen saturation, and diastolic pressure and the laboratory parameters such as the glucose, creatinine, white line cells, hemoglobin, D-dimer, and C-reactive protein, among others, were associated with critical illness (p: < 0.05). Finally, advanced age, previous hospital treatment, and the presence of one or more underlying diseases were associated with critical illness and death (p: < 0.02).

conclusionsSeveral epidemiological (e.g., age and occupation) and clinical factors (e.g., previous treatment, underlying diseases, and vital signs and laboratory parameters) were associated with critical illness and death in patients hospitalized with COVID-19. These data provide us with possible markers to avoid critical illness or death from COVID-19 in our region.

Indexed as

COVID-19Critical IllnessDisease ProgressionHospitalizationSARS-CoV-2AdultAgedFemaleHospital MortalityHumansMaleMexicoMiddle AgedPandemicsRetrospective StudiesRisk FactorsCOVID‐19critical illnessdeathMexicoSARS‐CoV‐2

Identifiers

PMID39013440
PMCPMC11251732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.